These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9662254)

  • 1. Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
    Marchetti A; Pellegrini S; Sozzi G; Bertacca G; Gaeta P; Buttitta F; Carnicelli V; Griseri P; Chella A; Angeletti CA; Pierotti M; Bevilacqua G
    Br J Cancer; 1998 Jul; 78(1):73-8. PubMed ID: 9662254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung tumours from non-smoking subjects: A p53-related genetic instability in a subset of cases.
    Pellegrini S; Bertacca G; Buttitta F; Bevilacqua G; Marchetti A
    Int J Mol Med; 1999 Oct; 4(4):419-24. PubMed ID: 10493985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
    Geradts J; Fong KM; Zimmerman PV; Minna JD
    Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients.
    Pylkkanen L; Wolff H; Stjernvall T; Tuominen P; Sioris T; Karjalainen A; Anttila S; Husgafvel-Pursiainen K
    Int J Oncol; 2002 Feb; 20(2):285-90. PubMed ID: 11788890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
    Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
    Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
    Liloglou T; Ross H; Prime W; Donnelly RJ; Spandidos DA; Gosney JR; Field JK
    Br J Cancer; 1997; 75(8):1119-24. PubMed ID: 9099958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
    Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.
    Westra WH; Offerhaus GJ; Goodman SN; Slebos RJ; Polak M; Baas IO; Rodenhuis S; Hruban RH
    Am J Surg Pathol; 1993 Mar; 17(3):213-20. PubMed ID: 8434702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene.
    Hong HH; Ton TV; Kim Y; Wakamatsu N; Clayton NP; Chan PC; Sills RC; Lahousse SA
    Toxicol Pathol; 2008 Jul; 36(5):720-6. PubMed ID: 18648094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
    Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.
    Malcić A; Jukić S; Anić I; Pavelić B; Kapitanović S; Kruslin B; Pavelić K
    J Oral Pathol Med; 2008 May; 37(5):294-301. PubMed ID: 18221322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.